Acute erythroleukemia: Diagnosis and management

Expert Review of Hematology

Volumn 3, Issue 6, 2010, Pages 705-718

  Santos, Fabio P S ^a,b   Bueso Ramos, Carlos E ^c   Ravandi, Farhad ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

acute erythroleukemia; classification; diagnosis; pathology; prognosis; therapy

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; 5,6 DIHYDROAZACITIDINE; ANTHRACYCLINE; CYTARABINE; NUCLEOSIDE ANALOG;

ACUTE ERYTHROLEUKEMIA; ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CHILDHOOD LEUKEMIA; CYTOCHEMISTRY; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; ERYTHROLEUKEMIA; FAMILIAL ERYTHROLEUKEMIA; HUMAN; IMMUNOPHENOTYPING; LABORATORY TEST; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROGNOSIS; PURE ERYTHROLEUKEMIA; REVIEW;

HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE;

EID: 78649515416     PISSN: 17474086     EISSN: None     Source Type: Journal    
DOI: 10.1586/ehm.10.62     Document Type: Review

References (108)

1. Swerdlow SH, Campo E, Harris NL et al. (Eds). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, France (2008).
2. Bennett JM, Catovsky D, Daniel MT et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br. J. Haematol. 33(4), 451-458 (1976).
3. Davey FR, Abraham N, Jr., Brunetto VL et al. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): A CALGB study. Am. J. Hematol. 49(1), 29-38 (1995).
4. Olopade OI, Thangavelu M, Larson RA et al. Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood 80(11), 2873-2882 (1992).
5. Bennett JM, Begg CB. Eastern Cooperative Oncology Group study of the cytochemistry of adult acute myeloid leukemia by correlation of subtypes with response and survival. Cancer Res. 41(11 Pt 2), 4833-4837 (1981).
6. Lowenberg B. Prognostic factors in acute myeloid leukaemia. Best Pract. Res. Clin. Haematol. 14(1), 65-75 (2001).
7. Copelli M. Di una emopatia sistemizzata rapresentata da una imperplasia eritroblastica (eritromatosis). Pathologica 4, 460 (1912).
8. Bain BJ. Di Guglielmo and his syndromes. Br. J. Haematol. 120(6), 939-943 (2003). Historical review on Di Guglielmo.
9. Di Guglielmo G. Richerche di ematologia. I. Un caso di eritroleucemia. Megacariociti in circolo e loro funzione piastrinopoietico. Folia Medica (Pavia) 13, 386 (1917).
10. Di Guglielmo G. L'eritremie. Haematologica 9, 301-347 (1928).
11. Baserga A. La Mielosi Eritremica Acuta. Mallatia di Di Guglielmo, Pavia, Italy (1938).
12. Storti F, Brotto M. Über die pathogenese der übertragbaren hühnerleukämie. Folia Haemat. 63, 1-33 (1939).
13. Moeschlin S. Erythroblastosen, erythroleukämien und erythroblastämien. Folia Haemat. 64, 262-302 (1940).
14. Di Guglielmo G. Les maladies érythremiques. Rev d'hémat. 1, 355-398 (1946).
15. Dameshek W, Baldini M. The Di Guglielmo syndrome. Blood 13(2), 192-194 (1958).
16. Bennett JM, Catovsky D, Daniel MT et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann. Intern. Med. 103(4), 620-625 (1985).
17. Garand R, Duchayne E, Blanchard D et al. Minimally differentiated erythroleukaemia (AML M6 'variant'): A rare subset of AML distinct from AML M6. Groupe Francais d'Hematologie Cellulaire. Br. J. Haematol. 90(4), 868-875 (1995).
18. Griesser GH, Horny HP. Hematopathological features of acute erythremia (morbus Di Guglielmo). A contribution to the classification and differential diagnosis of erythroid neoplasias. Acta Haematologica 77(4), 193-197 (1987).
19. Hasserjian RP, Howard J, Wood A, Henry K, Bain B. Acute erythremic myelosis (true erythroleukaemia): A variant of AML FAB-M6. J. Clin. Pathol 54(3), 205-209 (2001).
20. Kowal-Vern A, Cotelingam J, Schumacher HR. The prognostic significance of proerythroblasts in acute erythroleukemia. Am J. Clin. Pathol 98(1), 34-40 (1992).
21. Mazzella FM, Schumacher HR. Acute erythroleukemia M6b. Arch. Pathol. Lab. Med. 124(2), 330-331 (2000).
22. Mazzella FM, Smith D, Horn P et al. Prognostic significance of pronormoblasts in erythrocyte predominant myelodysplastic patients. Am. J. Hematol. 81(7), 484-491 (2006). Analyzes impact of proerythroblast percentage in patients with myelodysplastic syndromes with erythroid hyperplasia.
23. Shichishima T. Minimally differentiated erythroleukemia: Recognition of erythroid precursors and progenitors. Intern. Med. 39(10), 761-762 (2000).
24. Yonezumi M, Miyagishima T, Kudo M et al. A case of de novo early erythroblastic leukemia supporting a proposal of AML M6 'variant'. Leuk. Lymphoma 39(5-6), 667-668 (2000).
25. Greaves MF, Sieff C, Edwards PA. Monoclonal antiglycophorin as a probe for erythroleukemias. Blood 61(4), 645-651 (1983).
26. Villeval JL, Cramer P, Lemoine F et al. Phenotype of early erythroblastic leukemias. Blood 68(5), 1167-1174 (1986).
27. Mazzella FM, Kowal-Vern A, Shrit MA et al. Acute erythroleukemia: Evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics, and prognosis. Am. J. Clin. Pathol 110(5), 590-598 (1998).
28. Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, France (2001).
29. Zini G, d'Onofrio G. Epitaph for erythroleukemia. Haematologica 89(8), ELT11 (2004).
30. Hasserjian RP, Zuo Z, Garcia C et al. Acute erythroid leukemia: A reassessment using criteria refined in the 2008 WHO classification. Blood 115(10), 1985-1992 (2010). Describes the outcomes of patients with acute erythroid leukemia according to the 2008 WHO classification and compares their outcomes to patients with acute myeloid leukemia with myelodysplasiarelated changes with erythroid hyperplasia and other related subtypes of acute myeloid leukemia.
31. Domingo-Claros A, Larriba I, Rozman M et al. Acute erythroid neoplastic proliferations. A biological study based on 62 patients. Haematologica 87(2), 148-153 (2002). Series of 62 patients describing the morphological features of acute erythroid leukemia in detail.
32. Santos FP, Faderl S, Garcia-Manero G et al. Adult acute erythroleukemia: An analysis of 91 patients treated at a single institution. Leukemia 23(12), 2275-2280 (2009). Analysis of 91 patients with acute erythroid leukemia according to the WHO classification; compares their outcome and clinical features to other acute myeloid leukemia subtypes.
33. Kowal-Vern A, Mazzella FM, Cotelingam JD, Shrit MA, Rector JT, Schumacher HR. Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases. Am. J. Hematol. 65(1), 5-13 (2000).
34. Reiffers J, Bernard P, Larrue J et al. Acute erythroblastic leukemia presenting as acute undifferentiated leukemia: A report of two cases with ultrastructural features. Leuk. Res. 9(3), 413-420 (1985).
35. Kasyan A, Medeiros LJ, Zuo Z et al. Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease. Mod. Pathol. 23(8), 1113-1126 (2010). Describes the outcomes of patients with acute erythroid leukemia according to the 2008 WHO classification and compares their outcomes to patients with acute myeloid leukemia with myelodysplasiarelated changes with erythroid hyperplasia and other related subtypes of acute myeloid leukemia.
36. Colita A, Belhabri A, Chelghoum Y, Charrin C, Fiere D, Thomas X. Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: A retrospective study of 54 cases. Ann. Oncol. 12(4), 451-455 (2001).
37. Wells AW, Bown N, Reid MM, Hamilton PJ, Jackson GH, Taylor PR. Erythroleukaemia in the north of England: A population based study. J. Clin. Pathol. 54(8), 608-612 (2001).
38. Bjork J, Albin M, Mauritzson N, Stromberg U, Johansson B, Hagmar L. Smoking and acute myeloid leukemia: Associations with morphology and karyotypic patterns and evaluation of dose-response relations. Leuk. Res. 25(10), 865-872 (2001).
39. Gupta AD, Dhond SR. Phenotypic heterogeneity of erythroblasts in erythroblastic leukemia revealed by monoclonal antibodies. Am. J. Hematol. 29(1), 12-17 (1988).
40. Rosenthal S, Cancellos GP, Gralnick HP. Erythroblastic transformation of chronic granulocytic leukemia. Am. J. Med. 63(1), 116-124 (1977). (Pubitemid 8146658)
41. Weinfeld A, Westin J, Ridell B, Swolin B. Polycythaemia vera terminating in acute leukaemia. A clinical, cytogenetic and morphologic study in 8 patients treated with alkylating agents. Scand. J. Haematol. 19(3), 255-272 (1977).
42. Bank A, Larsen PR, Anderson HM. Di Guglielmo's syndrome after polycythemia. N. Engl. J. Med. 275(9), 489-490 (1966).
43. Atkinson J, Hrisinko MA, Weil SC. Erythroleukemia: A review of 15 cases meeting 1985 FAB criteria and survey of the literature. Blood Rev. 6(4), 204-214 (1992).
44. Park S, Picard F, Azgui Z et al. Erythroleukemia: A comparison between the previous FAB approach and the WHO classification. Leuk. Res. 26(5), 423-429 (2002).
45. Chevallier P, Mohty M, Lioure B et al. Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: A retrospective study from the SFGM-TC. J. Clin. Oncol. 26(30), 4940-4943 (2008).
46. Acin P, Woessner S, Florensa L, Sole F, Sans-Sabrafen J. Spiculated red cells in erythroleukemia. Eur. J. Haematol. 59(3), 190-193 (1997).
47. Atkins JN, Muss HB. Schistocytes in erythroleukemia. Am. J. Med. Sci. 289(3), 110-113 (1985).
48. Huang Q. Pure erythroid leukemia. Arch. Pathol. Lab. Med. 128(2), 241-242 (2004).
49. Sun T. Case 11. Acute erythroid leukemia. In: Flow Cytometry and Immunohistochemistry for Hematologic Neoplasms. Lippincott Williams & Wilkins, Philadelphia, PA, USA, 116-121 (2008).
50. Bain B. Leukaemia Diagnosis. Wiley-Blackwell, Chichester, West Sussex, UK (2010).
51. Sondergaard-Petersen H. Erythrophagocytosis by pathological erythroblasts in the Di Guglielmo syndrome. A study of 18 cases. Scand. J. Haematol. 13(4), 260-265 (1974).
52. Sondergaard-Petersen H. The Di Guglielmo syndrome: A study of 17 cases. I. Clinical and hematological manifestations. Acta. Med. Scand. 198(3), 165-174 (1975).
53. Kass L, Peters CL. Nonspecific esterase activity in pernicious anemia and chronic erythremic myelosis: A cytochemical and electrophoretic study. Am. J. Clin. Pathol. 68(2), 273-275 (1977). (Pubitemid 8140327)
54. Kass L. Esterase activity in erythroleukemia. Am. J. Clin. Pathol. 67(4), 368-370 (1977).
55. Mazzella FM, Alvares C, Kowal-Vern A, Schumacher HR. The acute erythroleukemias. Clin. Lab. Med. 20(1), 119-137 (2000).
56. Quaglino D, Hayhoe FG. Periodic-acid- Schiff positivity in erythroblasts with special reference to Di Guglielmo's disease. Br. J. Haematol. 6, 26-33 (1960).
57. Sondergaard-Petersen H. The Di Guglielmo syndrome: A study of 17 cases. II. Periodic-acid schiff staining of the erythroblasts. Acta. Med. Scand. 198(3), 175-182 (1975).
58. Frydecka I, Brodzka W, Lawinska B, Sciborski R. Clinical course and results of treatment of erythroleukaemia. Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. 111(3), 283-289 (1984).
59. Chasis JA, Mohandas N. Red blood cell glycophorins. Blood 80(8), 1869-1879 (1992).
60. Daniels L, Guerti K, Vermeulen K et al. Acute myeloid leukaemia of mixed megakaryocytic and erythroid origin: A case report and review of the literature. Acta Clin. Belg. 62(5), 308-314 (2007).
61. San Miguel JF, Gonzalez M, Canizo MC, Anta JP, Zola H, Lopez Borrasca A. Surface marker analysis in acute myeloid leukaemia and correlation with FAB classification. Br. J. Haematol. 64(3), 547-560 (1986).
62. Maynadie M, Bailly F, Casasnovas RO, Coudert B, Carli PM. Immunophenotype in erythroleukemia secondary to myelodysplastic syndrome. Blood 80(4), 1097 (1992).
63. Imamura N, Mtasiwa DM, Inada T, Kuramoto A. Different expression of CD36 antigen molecule on the surface of megakaryocyte lineage leukemias and megakaryocyte leukemia cell lines MEG-01 and HEL. Leukemia 4(7), 525-528 (1990).
64. Cuneo A, Van Orshoven A, Michaux JL et al. Morphologic, immunologic and cytogenetic studies in erythroleukaemia: Evidence for multilineage involvement and identification of two distinct cytogeneticclinicopathological types. Br. J. Haematol. 75(3), 346-354 (1990).
65. Villeval JL, Cramer P, Lemoine F et al. Phenotype of early erythroblastic leukemias. Blood 68(5), 1167-1174 (1986).
66. Desai PR. Immunoreactive T and Tn antigens in malignancy: Role in carcinoma diagnosis, prognosis, and immunotherapy. Transfus. Med. Rev. 14(4), 312-325 (2000).
67. Muroi K, Suda T, Nakamura M et al. Expression of sialosyl-Tn in colony-forming unit-erythroid, erythroblasts, B cells, and a subset of CD4+ cells. Blood 83(1), 84-91 (1994).
68. Muroi K, Amemiya Y, Sievers EL, Miura Y, Hakamori SI, Loken MR. Expression of sialosyl-T and disialosyl-T antigens in erythroid cells. Leuk. Lymphoma 25(5-6), 403-414 (1997).
69. Muroi K, Tarumoto T, Akioka T et al. Sialyl-Tn- and neuron-specific enolasepositive minimally differentiated erythroleukemia. Intern. Med. 39(10), 843-846 (2000).
70. Cao Y, Merling A, Karsten U et al. Expression of CD175 (Tn), CD175s (sialosyl-Tn) and CD176 (Thomsen- Friedenreich antigen) on malignant human hematopoietic cells. Int. J. Cancer 123(1), 89-99 (2008).
71. Acs G, LiVolsi VA. Loss of membrane expression of E-cadherin in leukemic erythroblasts. Arch. Pathol. Lab. Med. 125(2), 198-201 (2001).
72. Heath CW, Jr., Bennett JM, Whang-Peng J, Berry EW, Wiernick PH. Cytogenetic findings in erythroleukemia. Blood 33(3), 453-467 (1969).
73. Lessard M, Struski S, Leymarie V et al. Cytogenetic study of 75 erythroleukemias. Cancer Genet. Cytogenet. 163(2), 113-122 (2005).
74. Cigudosa JC, Odero MD, Calasanz MJ et al. De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19. Genes Chromosomes Cancer 36(4), 406-412 (2003). Detailed analysis of karyotype in acute erythroid leukemia by spectral karyotyping; describes new recurrent translocation in acute erythroid leukemia.
75. Nakamura H. Cytogenetic heterogeneity in erythroleukemia defined as M6 by the French-American-British (FAB) Cooperative Group criteria. Leukemia 3(4), 305-309 (1989).
76. Scholl C, Gilliland DG, Frohling S. Deregulation of signaling pathways in acute myeloid leukemia. Semin. Oncol. 35(4), 336-345 (2008).
77. Frohling S, Lipka DB, Kayser S et al. Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7. Blood 107(3), 1242-1243 (2006).
78. Murati A, Gelsi-Boyer V, Adelaide J et al. PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation. Leukemia 19(9), 1692-1696 (2005).
79. Heiss S, Erdel M, Gunsilius E, Nachbaur D, Tzankov A. Myelodysplastic/ myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): First description of a case. Hum. Pathol. 36(10), 1148-1151 (2005).
80. Mazzella FM, Tolbert D, Kowal-Vern A et al. p53 gene mutation in acute erythroleukemia: Differences among subtypes M6a, M6b and M6c. Lab. Hematol. 5(1), 28-36 (1999).
81. Barnard DR, Alonzo TA, Gerbing RB, Lange B, Woods WG. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: Report from the Children's Oncology Group. Pediatr. Blood Cancer 49(1), 17-22 (2007).
82. Allan RR, Wadsworth LD, Kalousek DK, Massing BG. Congenital erythroleukemia: A case report with morphological, immunophenotypic, and cytogenetic findings. Am. J. Hematol. 31(2), 114-121 (1989).
83. Bjure J, Fichtelius KE, Ranstrom S. On the problem of congenital hemopathies (congenital myeloid and erythremic blood picture). Acta Paediatr. 49, 358-370 (1960).
84. Hadjiyannakis A, Fletcher WA, Lebrun DP, van Wylick RC, Dow KE. Congenital erythroleukemia in a neonate with severe hypoxic ischemic encephalopathy. Am. J. Perinatol. 15(12), 689-694 (1998).
85. Haught EA, Johnson MC, Witt PD. Congenital erythroleukemia presenting as a congenital infantile hemangioma. Plast. Reconstr. Surg. 119(4), 70e-72e (2007).
86. Lasson U, Goos M. Congenital erythroleukemia. A case report. Blut 43(4), 237-241 (1981).
87. Lazure T, Beauchamp A, Croisille L, Ferlicot S, Feneux D, Fabre M. Congenital anerythremic erythroleukemia presenting as hepatic failure. Arch. Pathol. Lab. Med. 127(10), 1362-1365 (2003).
88. Davidson RJ, Walker W, Watt JL, Page BM. Familial erythroleukaemia: A cytogenetic and haematological study. Scand. J. Haematol. 20(4), 351-359 (1978).
89. He LZ, Lu LH, Chen ZZ. Genetic mechanism of leukemia predisposition in a family with 7 cases of acute myeloid leukemia. Cancer Genet. Cytogenet. 76(1), 65-69 (1994).
90. Lee EJ, Schiffer CA, Misawa S, Testa JR. Clinical and cytogenetic features of familial erythroleukaemia. Br. J. Haematol. 65(3), 313-320 (1987).
91. Nissenblatt MJ, Bias W, Borgaonkar D, Dixon S, Cody RP. Familial erythroleukemia: Four cases of the Diguglielmo syndrome in close relatives. Johns Hopkins Med. J. 150(1), 1-9 (1982).
92. Novik Y, Marino P, Makower DF, Wiernik PH. Familial erythroleukemia: A distinct clinical and genetic type of familial leukemias. Leuk. Lymphoma 30(3-4), 395-401 (1998).
93. Peterson HR Jr, Bowlds CF, Yam LT. Familial DiGuglielmo syndrome. Cancer 54(5), 932-938 (1984).
94. Siebert R, Jhanwar S, Brown K, Berman E, Offit K. Familial acute myeloid leukemia and DiGuglielmo syndrome. Leukemia 9(6), 1091-1094 (1995).
95. Kurita S, Kamei Y, Ota K. Genetic studies on familial leukemia. Cancer 34(4), 1098-1101 (1974).
96. Olopade OI, Roulston D, Baker T et al. Familial myeloid leukemia associated with loss of the long arm of chromosome 5. Leukemia 10(4), 669-674 (1996).
97. Selby DM, Valdez R, Schnitzer B, Ross CW, Finn WG. Diagnostic criteria for acute erythroleukemia. Blood 101(7), 2895-2896 (2003).
98. Mori T, Kaneko H, Kumagai MA et al. Congenital leukaemia with a mixed phenotype of megakaryoblasts and erythroblasts: A case report and characterization of the blasts. Br. J. Haematol. 96(4), 740-742 (1997).
99. Pulsoni A, Breccia M, Orlando SM et al. Acute erythroid leukemia: A distinctive subtype of AML? Outcome and prognostic factors in comparison with non-M6 AML. The gimema experience. Presented at: 51st ASH Annual Meeting and Exposition. New Orleans, LA, USA, 5-8 December 2009 (Abstract 1019).
100. Goldberg SL, Noel P, Klumpp TR, Dewald GW. The erythroid leukemias: A comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease. Am. J. Clin. Oncol. 21(1), 42-47 (1998).
101. Mazzella FM, Kowal-Vern A, Shrit MA, Rector JT, Cotelingam JD, Schumacher HR. Effects of multidrug resistance gene expression in acute erythroleukemia. Mod. Pathol. 13(4), 407-413 (2000).
102. Fouillard L, Labopin M, Gorin NC et al. Hematopoietic stem cell transplantation for de novo erythroleukemia: A study of the European Group for Blood and Marrow Transplantation (EBMT). Blood 100(9), 3135-3140 (2002).
103. Garcia-Manero G. Demethylating agents in myeloid malignancies. Curr. Opin. Oncol. 20(6), 705-710 (2008).
104. Vigil C, Cortes J, Kantarjian HM, Garcia-Manero G, Lancet JE, List AF. Hypomethylating therapy for the treatment of acute erythroleukemia patients. Presented at: 51st ASH Annual Meeting and Exposition. New Orleans, LA, USA, 5-8 December 2009 (Abstract 2069).
105. Camera A, Volpicelli M, Villa MR, Risitano AM, Rossi M, Rotoli B. Complete remission induced by high dose erythropoietin and granulocyte colony stimulating factor in acute erythroleukemia (AML-M6 with maturation). Haematologica 87(11), 1225-1227 (2002).
106. Ferraris AM, Canepa L, Mareni C et al. Reexpression of normal stem cells in erythroleukemia during remission. Blood 62(1), 177-179 (1983).
107. Berneman ZN, van Bockstaele DR, Van den Bergh M et al. Karyotypic evidence for the leukemic involvement of the erythroblasts in erythroleukemia. Leukemia 2(5), 296-299 (1988).
108. Wong KF, Chu YC, Kwong YL. Abnormal erythropoiesis in erythroleukemia: A fluorescence in situ hybridization study. Cancer Genet. Cytogenet. 105(2), 187-189 (1998).